Print to PDF
  • About Us
  • Privacy
  • Contact Us

Contact Lens Update

Clinical Insights Based in Current Research

Search Our Site

  • Home
  • Browse Past Issues
  • Resource Library
  • Back to Basics
  • Useful Links
  • About Us
  • Contact Us

Summary: Pathophysiology report

October 6th, 2017

Download PDF

Marc SchulzeMarc Schulze is a clinical scientist at the Centre for Contact Lens Research, in the School of Optometry and Vision Science at the University of Waterloo, Canada. 

Bron et al.: TFOS DEWS II pathophysiology report. Ocul Surf 2017;15(3): 438-510.

The report on pathophysiology lists two main sub-types of dry eye: aqueous tear-deficient and evaporative, initially established in the 1995 NEI/Industry workshop on dry eye disease1 and further described in the 2007 dry eye report from the Tear Film and Ocular Surface Society (TFOS).2

Aqueous tear-deficient dry eye

Aqueous deficient dry eye (ADDE) describes eyes that have a normal rate of tear evaporation, but where insufficient tears are secreted (for example due to lacrimal gland damage), resulting in hyperosmolarity of the tears. Typical causes of ADDE include lacrimal gland obstruction, the use of systemic drugs such as anti-histamines or Betablockers, or immune cell infiltration of the lacrimal glands as found in patients with auto-immune disorders such as Sjögren syndrome. Patients with ADDE often report dry eye symptoms that include blurred vision, grittiness and ocular discomfort, along with clinical signs such as tear film instability and conjunctival staining.

Evaporative dry eye

Evaporative dry eye (EDE) describes eyes with normal lacrimal function but excessive evaporation of the tear film, leading to tear hyperosmolarity. Meibomian gland dysfunction is considered the major cause of EDE. Hybrid forms of ADDE and EDE exist, as found in Sjögren’s syndrome, which can include both lacrimal deficiency as well as meibomian gland disease.

According to the pathophysiology sub-committee, the use of the terms EDE and ADDE should be retained to describe the initiating basis of dry eye disease. Depending on its progression, any form of dry eye disease may take on additional evaporative features, and should be described and referred to accordingly.

Mechanisms of dry eye

Dry eye disease is initiated by desiccating stress and a chain of inflammatory events that lead to hyperosmolar tissue damage and ultimately a vicious circle (Figure 1) of disease.

The core mechanism of dry eye disease is tear hyperosmolarity, which:

  • is caused by evaporation from the ocular surface, in both ADDE and EDE. Irrespective of dry eye disease type, additional evaporation may occur due to environmental (e.g. wind, humidity) and/or personal factors (blink rate, aperture size);
  • causes ocular surface damage, both directly and by initiating inflammation;
  • sets up a series of signaling events within epithelial cells on the ocular surface. Due to these events, various inflammatory mediators and proteases are released, which may lead to a loss of both epithelial cells and goblet cells, and decreased surface wettability, which is associated with a quicker tear film break-up and increased hyperosmolarity.

The vicious circle of dry eye disease: multiple entry points

Although tear hyperosmolarity is a frequent starting point for dry eye disease, any dry eye etiology may have other (and at times multiple) entry points into the vicious circle (Figure 1), with tear hyperosmolarity and inflammatory events being the common denominators after it has been entered.

Tear film instability is an example of a different entry point into the vicious circle in patients with EDE, where tear film instability may be caused by conditions such as ocular allergy or because of topical preservative use or contact lens wear; in these cases, tear film instability is considered to be the initiator for tear hyperosmolarity to occur.

Figure 1: The vicious circle of dry eye disease

Figure 1: The vicious circle of dry eye disease3

REFERENCES:

  1. Lemp MA. Report of the National Eye Institute/ industry workshop on clinical trials in dry eyes. CLAO J 1995;21:221-2.
  2. Report of the international dry eye workshop (DEWS). Ocul Surf 2007;5:65-204.
  3. Bron et al.: TFOS DEWS II pathophysiology report. Ocul Surf 2017;15(3): 438-510.

For further details, please refer to The TFOS DEWS II Pathophysiology report

Issues

  • Multifocal Contact Lenses
  • Artificial Tears: An Update
  • Myopia: New Evidence and Best Practices
  • Neuropathic Pain
  • Specialty Rigid Lenses
  • Contact lens compliance
  • Pandemic update
  • Digital Devices and Dry Eye: A Growing Issue
  • The long and short of axial length
  • Using BCLA CLEAR with your patients
  • Helping your patients through allergy season
  • Getting the measure of meibomian glands
  • 2020: An extraordinary year
  • Scleral lens update
  • A dose of myopia
  • New news since TFOS DEWS II
  • COVID-19 Special Edition
  • Material considerations
  • Putting dry eye theory into practice
  • Getting started with Ortho-K
  • Infiltrates – an update
  • Staining
  • Myopia matters: Summarising the IMI reports
  • Lids and contact lenses
  • Myths
  • Revisiting patient compliance
  • Contact Lenses & Kids
  • Interprofessional Collaboration
  • Digital eye strain
  • New Dry Eye Technology
  • Update on Presbyopia
  • Taking stock of dry eye disease: DEWS II
  • Scleral Lenses
  • Pain and Sensation
  • Lab measurements in clinical practice
  • Control of pediatric myopia
  • Nutrition
  • Rethinking contact lens deposits
  • Extended wear
  • Daily Disposables
  • Eyelash Mites (Demodex)
  • Outsmarting bacteria with new technology
  • Youth and contact lenses
  • Sports Vision
  • Ocular effects of UV radiation from the sun
  • Eyelid Conditions
  • Makeup: Impact on ocular health
  • Myopia Control – Update 2014
  • The Growing Prevalence of Myopia
  • Cosmetic contact lenses
  • Contact lens discomfort – The essentials
  • Technology and contact lens research
  • It's A Question of Comfort
  • Contact lens materials
  • Let's talk about SICS
  • Conjunctival Controversies
  • Kids & Contact Lenses
  • One-day silicone hydrogel lenses
  • Solutions
  • Spotlight on Scleral lenses
  • Drug delivery via contact lenses
  • Ocular allergies
  • Reducing lens case contamination
  • Dry eye and meibomium gland dysfunction
  • Myopia Control
  • Presbyopia
  • Compliance and non-compliance
  • Lens care
  • Celebrating 50 years of contact lenses

Looking for another article?

Alcon coopervision Johnson&Johnson Vision Care

Newsletter Sign-Up

Sign-up for and start receiving our newsletter.

Site Map

  • Home
  • Browse Past Issues
    • Editorial
    • Feature Article
    • Clinical Insight
    • Conference Highlights
  • Resource Library
  • Back to Basics
  • Useful Links
  • About Us
  • Contact Us
© 2023 Contact Lens Update